Effect Of High Tone Power Therapy On Selected Symptoms In Post Covid Syndrome
WHO
1 other identifier
interventional
56
1 country
1
Brief Summary
The Coronavirus Disease 2019 (COVID-19) is a highly transmittable and pathogenic viral infection caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2), which emerged in Wuhan, China in December 2019 and its spread around the world has been rapid (Rathi et al., 2021; Vakili et al., 2021). COVID-19 impacts on economy, society, education , neurological, psychiatric and psychosocial impairments , increasing the burden of disease and disability throughout the world have been studied by several authors (Phillips et al., 2020; Pragholapati, 2020). COVID-19 may lead to greater risks of long-term scarring, permanently lower economic activity, a significant increase in the prevalence of chronic illness, social distancing, isolation, changes in teaching and learning strategies to decrease of number of days of education, the number of social contacts each day is limited (Minister \& Majesty, 2020; Almomani et al., 2021) .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2021
CompletedFirst Submitted
Initial submission to the registry
January 24, 2022
CompletedFirst Posted
Study publicly available on registry
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2022
CompletedFebruary 1, 2022
January 1, 2022
1 year
January 24, 2022
January 28, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Six-Minute Walk Test
for functional capacity
4 weeks
Chalder Fatigue Scale: score can range from 0 to 33, with a higher score indicating greater fatigue.
for chronic Fatigue
4 weeks
Study Arms (2)
High tone power therapy group
EXPERIMENTALpatients in this group will receive High tone power therapy from 30 to 60 minutes, 3 session /week for 4 weeks with total sessions at least l0 sessions and self-stretch for hand and shoulder.
control group
EXPERIMENTALPatients in control group will receive high tone sham therapy 3 times per week and self-stretch for hand and shoulder.
Interventions
patients in this group will receive High tone power therapy from 30 to 60 minutes, 3 session /week for 4 weeks with total sessions at least l0 sessions and self-stretch for hand and shoulder.
Eligibility Criteria
You may qualify if:
- All patients were diagnosed with COVID-19 by polymerase chain reaction (PCR) test of a nasopharyngeal sample during acute phase, completed CBC, lymphocyte inflammatory marker, c-reactive protein and ESR.
- Patients must be negative polymerase chain reaction (PCR).
- Patients will be completely recovered from acute symptoms of covid-19.
- Patients will be recruited after 2- 4 weeks post complete recovery from acute symptoms
You may not qualify if:
- Patients with feverish systemic or local bacterial infections.
- Epilepsy.
- Pregnant women patients.
- Cancer.
- Uncontrolled Diabetes milletus \>250 mg/dl
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emad
Cairo, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer assistant
Study Record Dates
First Submitted
January 24, 2022
First Posted
February 1, 2022
Study Start
November 10, 2021
Primary Completion
November 20, 2022
Study Completion
November 20, 2022
Last Updated
February 1, 2022
Record last verified: 2022-01